Number To Know…2.3 billion
$2.3bn is the predicted size of the biopsy device market by 2021, fueled by increased rates of cancer and a boom in market growth in countries outside of the US.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.